Earth Science Tech Inc (ETST)
OTHER OTC:ETST
Top Page
Earth Science Tech
(OTC:ETST)
Select Model
Select Model
Rating:71Outperform
Price Target:
$0.12
▼(-11.54% Downside)
Action:UpgradedDate:04/09/26
The score is driven primarily by strong financial performance (profitability, positive cash generation, and very low leverage), supported by constructive corporate developments (telehealth platform expansion and governance upgrade). Offsetting these positives, technical indicators show a weak trend with the stock below key moving averages and negative MACD, limiting the overall score despite a modest P/E.
Positive Factors
Conservative balance sheet
Extremely low leverage provides durable financial flexibility, lowering refinancing and bankruptcy risk while enabling capital allocation to growth, acquisitions, or buybacks. For a small, diversified health operator this supports stability across cyclical revenue swings and expansion plans.
Negative Factors
Historical financial instability
Prior episodes of negative equity and volatility highlight structural risk: management must sustain current profitability and capital discipline to avoid recurrence. Small missteps or slower growth could quickly reverse reserves and force dilutive financing or asset sales.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Extremely low leverage provides durable financial flexibility, lowering refinancing and bankruptcy risk while enabling capital allocation to growth, acquisitions, or buybacks. For a small, diversified health operator this supports stability across cyclical revenue swings and expansion plans.
Read all positive factors
Earth Science Tech (ETST) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$34.97M
Dividend YieldN/A
Average Volume (3M)44.92K
Price to Earnings (P/E)10.5
Beta (1Y)2.61
Revenue Growth25.83%
EPS Growth25.00%
CountryUS
Employees32
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)<0.01
Shares Outstanding291,394,600
10 Day Avg. Volume74,750
30 Day Avg. Volume44,925
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)9.85
Price to Sales (P/S)1.15
P/FCF Ratio10.48
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue1.00
Enterprise Value/Gross Profit1.54
Enterprise Value/Ebitda7.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.05
Revenue Forecast (FY)$86.36M
Earth Science Tech Business Overview & Revenue Model
Company Description
Earth Science Tech, Inc., a biotechnology company, focuses on delivering nutraceuticals, bioceuticals, and dietary supplements in the areas of health, wellness, nutrition, supplement, cosmetic, and alternative medicine worldwide. The company focus...
How the Company Makes Money
Earth Science Tech generates revenue primarily through the sale of its hemp-derived CBD products, health supplements, and medical devices. The company benefits from direct sales to consumers, partnerships with distributors, and collaborations with...
Earth Science Tech Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
88
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Jun 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.87M | 33.12M | 11.95M | 48.54K | 14.12K | 140.90K |
| Gross Profit | 22.70M | 24.30M | 7.83M | 22.06K | -8.52K | 39.93K |
| EBITDA | 4.63M | 3.54M | 1.04M | -300.48K | -224.28K | -4.30M |
| Net Income | 3.49M | 3.25M | 812.14K | 144.58K | 6.66M | -4.47M |
Balance Sheet | ||||||
| Total Assets | 8.09M | 7.07M | 3.88M | 2.69M | 76.94K | 64.56K |
| Cash, Cash Equivalents and Short-Term Investments | 1.54M | 2.12M | 697.72K | 35.76K | 26.94K | 16.16K |
| Total Debt | 197.05K | 401.24K | 246.59K | 974.11K | 682.45K | 650.44K |
| Total Liabilities | 2.29M | 3.22M | 1.63M | 1.61M | 1.88M | 5.09M |
| Stockholders Equity | 5.73M | 3.85M | 2.25M | 1.08M | -1.81M | -5.03M |
Cash Flow | ||||||
| Free Cash Flow | 2.50M | 3.62M | 1.18M | -1.01M | -166.39K | -196.69K |
| Operating Cash Flow | 3.05M | 4.37M | 1.21M | -1.01M | -168.11K | -196.69K |
| Investing Cash Flow | -1.51M | -1.88M | -26.52K | 0.00 | 1.71K | 0.00 |
| Financing Cash Flow | -1.64M | -1.72M | -517.88K | 1.02M | 173.18K | 182.12K |
Earth Science Tech Technical Analysis
Positive
0.13
Price Trends
0.12
Positive
0.13
Negative
0.16
Negative
Market Momentum
>-0.01
Negative
58.39
Neutral
81.38
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ETST, the sentiment is Positive. The current price of 0.13 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.12, and below the 200-day MA of 0.16, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 58.39 is Neutral, neither overbought nor oversold. The STOCH value of 81.38 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ETST.
Earth Science Tech Risk Analysis
Earth Science Tech disclosed 38 risk factors in its most recent earnings report. Earth Science Tech reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Earth Science Tech Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $34.97M | 10.53 | 71.39% | ― | 25.83% | 25.00% | |
55 Neutral | $44.31M | -3.67 | -19.05% | ― | -65.77% | 38.61% | |
54 Neutral | $36.65M | -5.64 | -15.64% | ― | -23.60% | -179.33% | |
53 Neutral | $46.52M | -20.99 | -10.54% | ― | 12.21% | 69.91% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | $40.65M | -3.20 | -118.01% | ― | -90.04% | 44.40% | |
40 Underperform | $10.86M | -1.59 | -63.82% | ― | ― | ― |
* Healthcare Sector Average
ETST
Earth Science Tech
0.12
0.00
0.00%
TLPH
Talphera
0.81
0.32
65.71%
RMTI
Rockwell Med
0.93
-0.14
-13.08%
SCYX
SCYNEXIS
0.99
0.12
13.24%
CPIX
Cumberland Pharmaceuticals
3.11
-0.92
-22.83%
COSM
Cosmos Holdings
0.29
-0.06
-16.91%
Earth Science Tech Corporate Events
Business Operations and StrategyFinancial DisclosuresProduct-Related Announcements
Earth Science Tech Launches Vertically Integrated Telehealth Platform
Positive
Mar 24, 2026
On March 24, 2026, Earth Science Tech, Inc. announced the official launch of MyOnlineConsultation.com through its MOCTeledoc, LLC unit, completing what it describes as a fully vertically integrated telehealth and pharmacy ecosystem. The platform c...
Business Operations and StrategyRegulatory Filings and Compliance
Earth Science Tech Appoints New Independent PCAOB Auditor
Positive
Feb 20, 2026
On February 17, 2026, Earth Science Tech, Inc., a strategic holding company focused on a diversified, vertically integrated health and wellness portfolio that includes compounding pharmacies, telemedicine platforms, healthcare facilities, real est...
Business Operations and StrategyStock BuybackFinancial Disclosures
Earth Science Tech Reports Strong Q3 2026 Financial Performance
Positive
Feb 17, 2026
Earth Science Tech, Inc., a diversified health and wellness holding company with compounding pharmacies, telemedicine platforms, healthcare facilities, and ancillary real estate and consumer brands, reported strong third fiscal quarter 2026 result...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.